Changes in Lipid Concentrations in Patients with Type 2 Diabetes on Once-Weekly Dulaglutide 1.5 mg: Post-hoc Pooled Analysis of the AWARD Trials

被引：0
|
作者：
Sattar, Naveed A.
Garcia-Perez, Luis E.
Tao, Yebin
Thieu, Vivian T.
Pavo, Imre
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1090-P
引用
收藏
页码：A288 / A289
页数：2
相关论文
共 50 条
  • [1] Changes in lipid concentrations in patients with type 2 diabetes on once-weekly dulaglutide 1.5 mg: post hoc pooled analysis of the AWARD trials
    Pavo, I.
    Garcia-Perez, L. -E.
    Tao, Y.
    Thieu, V. T.
    Sattar, N. A.
    [J]. DIABETOLOGIA, 2017, 60 : S258 - S258
  • [2] Efficacy and safety of once-weekly semaglutide low dose 0.5 mg vs once-weekly dulaglutide high dose 1.5 mg in type 2 diabetes: a post hoc analysis of SUSTAIN 7
    Pratley, R. E.
    Aroda, V. R.
    Gondolf, T.
    Hansen, T.
    Lingvay, I.
    Ludemann, J.
    Skjoth, T. V.
    Viljoen, A.
    [J]. DIABETOLOGIA, 2019, 62 : S374 - S374
  • [3] Once-Weekly Dulaglutide 3 mg and 4.5 mg Gastrointestinal Tolerability: Post-hoc Analysis of Incidence and Prevalence in Award-11
    Van, Joanna
    Frias, Juan P.
    Bonora, Enzo
    Raha, Sohini
    Jung, Heike
    Cox, David
    Konig, Manige
    Peleshok, Jennifer
    [J]. DIABETES, 2021, 70
  • [4] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Kuang, Jian
    Zhu, Jiankun
    Liu, Siying
    Li, Quanmin
    [J]. DIABETES THERAPY, 2020, 11 (10) : 2329 - 2339
  • [5] Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
    Jian Kuang
    Jiankun Zhu
    Siying Liu
    Quanmin Li
    [J]. Diabetes Therapy, 2020, 11 : 2329 - 2339
  • [6] Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials
    Lixin Guo
    Bin Zhang
    Jianing Hou
    Zhiguang Zhou
    [J]. Diabetes Therapy, 2020, 11 : 1821 - 1833
  • [7] Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials
    Guo, Lixin
    Zhang, Bin
    Hou, Jianing
    Zhou, Zhiguang
    [J]. DIABETES THERAPY, 2020, 11 (08) : 1821 - 1833
  • [8] Effect of Once-Weekly Dulaglutide 3.0 and 4.5 mg in Patients with Different Baseline Renal Function: Post-hoc Analysis from the Award-11 Trial
    Garcia-Perez, Luis-Emilio
    Maldonado, Juan M.
    Ranta, Kari T.
    Raha, Sohini
    [J]. DIABETES, 2021, 70
  • [9] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Patel, Hiren
    Munir, Kashif
    Sutherland, Sindee
    Karanikas, Chrisanthi A.
    Konig, Manige
    [J]. DIABETES THERAPY, 2019, 10 (06) : 2321 - 2330
  • [10] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Hiren Patel
    Kashif Munir
    Sindee Sutherland
    Chrisanthi A. Karanikas
    Manige Konig
    [J]. Diabetes Therapy, 2019, 10 : 2321 - 2330
12345